RecruitingNot applicableNCT05833217

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Tracey McLaughlin, MD
Stanford School of Medicine
Intervention
Adipose Tissue Biopsy(procedure)
Enrollment
55 target
Eligibility
18-80 years · All sexes
Timeline
20232025

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05833217 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials